PHARMACEUTICAL COMPOSITIONS COMPRISING INSULIN SENSITIZER AND INSULIN SECRETAGOGUE

摘要

Dosage forms containing an insulin sensitizer, such as pioglitazone, and an insulin secretogogue, such as glimepiride, are described. Including a cellulose derivative in the dosage form increased the dissolution rate of the insulin sensitizer and/or the insulin secretagogue.